Metabolic
Liraglutide
Saxenda / Victoza
- Peptide length
- 31 amino acids
Acylated peptide analog
Research contextDefined therapeutic evidence
Read the linked studies for their methods and limitations.
A GLP-1 receptor agonist with regulated diabetes and weight-management products and randomized weight-management evidence.
- Family
- Incretin analog
- Research frame
- GLP-1 receptor
- Molecular format
- Acylated peptide analog
Read the evidence
The SCALE trial studied a defined formulation, population and duration. Different liraglutide products have different labeled uses.
Resolve the identity
Confirm the peptide modification, acyl chain and finished formulation; shared GLP-1 activity does not imply equal pharmacokinetics.